New COPD combo shows promise in early trial
NCT ID NCT07132983
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a new combination of two inhaled drugs, ensifentrine and glycopyrrolate, in 33 adults with COPD. The goal was to see how the drugs move through the body, how well they open airways, and if they are safe. Each person received single doses of the combination and each drug alone. The results will help decide if this combo should be tested further.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Ensifentrine and glycopyrrolate (inhaled drugs)
What this could lead to
If successful, this combination could offer a new option to help people with COPD breathe easier by opening airways and reducing inflammation.
What could go wrong
This is a small, early-phase study (33 people) looking at short-term effects. It may not lead to a better treatment, and side effects are still being evaluated.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinical Research of West Florida Inc - Clearwater
Clearwater, Florida, 33765-2616, United States
-
Clinical Research of West Florida Inc - Tampa
Tampa, Florida, 33606-1246, United States
-
Midwest Chest Consultants PC
Saint Charles, Missouri, 63301, United States
-
Velocity Clinical Research - Spartanburg - PPDS
Spartanburg, South Carolina, 29303-4225, United States